Pharmaceutical major Nicholas Piramal India is planning to phase out its tertiary brands which accounted for 9 per cent of its revenue during 2001-02.
Pharmaceutical major Nicholas Piramal India is planning to phase out its tertiary brands which accounted for 9 per cent of its revenue during 2001-02.
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jun 11 2002 | 12:00 AM IST